Novel application of bortezomib in abrogating antibodies against ERT in Pompe disease: A strategy for broad clinical application in diseases treated with therapeutic proteins
Publication
, Conference
Banugaria, SG; Prater, SN; Nampoothiri, S; Feldman, J; Kobori, JA; McGann, JK; Koeberl, DD; Kishnani, PS
Published in: MOLECULAR GENETICS AND METABOLISM
March 1, 2011
Duke Scholars
Published In
MOLECULAR GENETICS AND METABOLISM
ISSN
1096-7192
Publication Date
March 1, 2011
Volume
102
Issue
3
Start / End Page
245 / 245
Location
Pacific Groove, CA
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Conference Name
34th Annual Meeting of the Society-for-Inherited-Metabolic-Disorders (SIMD 2011)
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Banugaria, S. G., Prater, S. N., Nampoothiri, S., Feldman, J., Kobori, J. A., McGann, J. K., … Kishnani, P. S. (2011). Novel application of bortezomib in abrogating antibodies against ERT in Pompe disease: A strategy for broad clinical application in diseases treated with therapeutic proteins. In MOLECULAR GENETICS AND METABOLISM (Vol. 102, pp. 245–245). Pacific Groove, CA: ACADEMIC PRESS INC ELSEVIER SCIENCE.
Banugaria, S. G., S. N. Prater, S. Nampoothiri, J. Feldman, J. A. Kobori, J. K. McGann, D. D. Koeberl, and P. S. Kishnani. “Novel application of bortezomib in abrogating antibodies against ERT in Pompe disease: A strategy for broad clinical application in diseases treated with therapeutic proteins.” In MOLECULAR GENETICS AND METABOLISM, 102:245–245. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2011.
Banugaria SG, Prater SN, Nampoothiri S, Feldman J, Kobori JA, McGann JK, et al. Novel application of bortezomib in abrogating antibodies against ERT in Pompe disease: A strategy for broad clinical application in diseases treated with therapeutic proteins. In: MOLECULAR GENETICS AND METABOLISM. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2011. p. 245–245.
Banugaria, S. G., et al. “Novel application of bortezomib in abrogating antibodies against ERT in Pompe disease: A strategy for broad clinical application in diseases treated with therapeutic proteins.” MOLECULAR GENETICS AND METABOLISM, vol. 102, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2011, pp. 245–245.
Banugaria SG, Prater SN, Nampoothiri S, Feldman J, Kobori JA, McGann JK, Koeberl DD, Kishnani PS. Novel application of bortezomib in abrogating antibodies against ERT in Pompe disease: A strategy for broad clinical application in diseases treated with therapeutic proteins. MOLECULAR GENETICS AND METABOLISM. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2011. p. 245–245.
Published In
MOLECULAR GENETICS AND METABOLISM
ISSN
1096-7192
Publication Date
March 1, 2011
Volume
102
Issue
3
Start / End Page
245 / 245
Location
Pacific Groove, CA
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Conference Name
34th Annual Meeting of the Society-for-Inherited-Metabolic-Disorders (SIMD 2011)
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences